tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

TScan Therapeutics Inc

TCRX
Add to Watchlist
0.355USD
+0.024+7.25%
Close 09-22 16:00（ET）
23.72MMarket Cap
LossP/E TTM
After-hours 18:05 (ET)0.359USD+0.007+1.99%

TScan Therapeutics Inc

0.355
+0.024+7.25%
Overview
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

TCRX Financials

See TScan Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
23.72M
Dividend TTM
0.00
P/E TTM
-0.37
EPS TTM
-0.96
Revenue
10.32M
Net Profit
-127.50M
ROE
-80.95%
ROA
-46.50%

TScan Therapeutics Inc Earnings Date

Latest Release
Aug 12, 2026
EPS / Forecast
-0.23/-0.21
Revenue / Forecast
1.05M/1.67M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
17.98%-0.23
16.16%-0.22
40.29%-0.18
-9.23%-0.28
-2.04%-0.28
17.16%-0.26
-43.92%-0.30
-3.83%-0.25
45.19%-0.28
65.89%-0.32
73.52%-0.21
---0.24
---0.51
---0.93
---0.78
---1.98
----
----
----
----
Revenue
-65.83%1.05M
-54.77%982.00K
286.02%2.57M
139.37%2.51M
473.88%3.08M
283.57%2.17M
-90.78%665.00K
-73.01%1.05M
-82.97%536.00K
-91.68%566.00K
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.80M
8.44%3.10M
39.43%3.36M
42.42%4.06M
49.04%3.02M
258.99%2.85M
731.72%2.41M
Net Profit
17.84%-30.36M
16.00%-28.67M
35.83%-22.98M
-19.48%-35.71M
-16.71%-36.95M
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
Net Margin
-140.45%-2888.58%
-85.70%-2919.14%
83.38%-895.09%
50.08%-1422.14%
79.66%-1201.30%
70.48%-1571.95%
-1879.80%-5384.81%
-381.56%-2849.09%
-673.34%-5906.90%
-1505.68%-5325.44%
55.04%-271.99%
---591.64%
---763.82%
---331.66%
---604.94%
---454.96%
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
Debt to assets ratio
76.74%19.12%
67.13%16.17%
64.55%14.22%
40.37%12.36%
33.18%10.82%
-22.98%9.67%
-21.73%8.64%
-14.31%8.81%
-13.39%8.12%
-26.11%12.56%
-24.95%11.04%
--10.28%
--9.38%
--17.00%
--14.71%
--17.57%
----
----
----
----
Income Statement
Revenue
-65.83%1.05M
-54.77%982.00K
286.02%2.57M
139.37%2.51M
473.88%3.08M
283.57%2.17M
-90.78%665.00K
-73.01%1.05M
-82.97%536.00K
-91.68%566.00K
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.80M
8.44%3.10M
39.43%3.36M
42.42%4.06M
49.04%3.02M
258.99%2.85M
731.72%2.41M
Operating profit
21.11%-30.49M
19.62%-29.14M
40.46%-21.86M
-13.58%-37.05M
-13.31%-38.65M
-15.55%-36.25M
-71.90%-36.71M
-31.82%-32.62M
-38.62%-34.11M
-37.95%-31.37M
-14.52%-21.36M
-49.28%-24.75M
-61.42%-24.61M
-40.71%-22.74M
-31.31%-18.65M
-4.65%-16.58M
-42.77%-15.25M
-104.13%-16.16M
-81.84%-14.20M
-120.92%-15.84M
Net Profit
17.84%-30.36M
16.00%-28.67M
35.83%-22.98M
-19.48%-35.71M
-16.71%-36.95M
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
Balance Sheet
Current assets
-52.79%104.40M
-47.90%132.77M
-46.29%157.21M
-31.35%188.16M
-26.17%221.13M
54.71%254.84M
50.70%292.72M
25.98%274.08M
23.66%299.53M
63.24%164.72M
56.48%194.24M
54.11%217.57M
87.24%242.22M
-30.77%100.91M
-25.07%124.13M
-24.51%141.18M
17.53%129.36M
17.66%145.75M
--165.65M
--187.00M
Total current liabilities
-1.14%30.96M
-33.02%19.97M
-48.01%18.70M
1.91%29.21M
-18.80%31.32M
-5.28%29.82M
20.58%35.96M
-13.55%28.66M
9.84%38.57M
124.10%31.48M
72.32%29.82M
99.78%33.15M
104.53%35.12M
-23.93%14.05M
-18.92%17.30M
-27.68%16.59M
-16.72%17.17M
-1.98%18.46M
--21.34M
--22.94M
Total assets
-42.57%171.45M
-39.29%201.99M
-38.35%228.79M
-24.65%262.23M
-20.36%298.56M
38.15%332.71M
36.37%371.12M
19.44%348.03M
18.28%374.87M
38.75%240.83M
36.70%272.15M
76.11%291.38M
107.93%316.92M
3.19%173.58M
5.84%199.09M
-19.25%165.45M
17.24%152.41M
19.34%168.20M
--188.11M
--204.89M
Total liabilities
-15.93%102.43M
-14.23%105.07M
-18.81%105.67M
-0.62%118.20M
1.84%121.85M
3.94%122.51M
7.31%130.15M
-2.84%118.94M
-5.28%119.65M
23.34%117.86M
21.70%121.28M
150.88%122.42M
508.37%126.32M
324.52%95.56M
264.66%99.66M
58.35%48.80M
-32.20%20.76M
-28.43%22.51M
--27.33M
--30.82M
Total equity
-60.94%69.02M
-53.89%96.92M
-48.91%123.12M
-37.13%144.02M
-30.76%176.71M
70.94%210.20M
59.72%240.97M
35.59%229.09M
33.90%255.22M
57.61%122.97M
51.73%150.87M
44.83%168.96M
44.78%190.61M
-46.45%78.02M
-38.15%99.43M
-32.98%116.66M
32.47%131.65M
33.07%145.69M
--160.78M
--174.07M
Cash Flow Statement
Net operating income
17.23%-27.54M
35.40%-24.28M
-16.74%-32.00M
-16.28%-32.46M
-26.85%-33.27M
-28.42%-37.59M
-15.34%-27.41M
-448.24%-27.92M
-19.09%-26.23M
-24.08%-29.27M
-48.44%-23.77M
147.15%8.02M
-64.75%-22.02M
-17.21%-23.59M
-11.34%-16.01M
-24.65%-17.00M
-24.93%-13.37M
-102.11%-20.12M
-95.65%-14.38M
-135.62%-13.64M
Net investment
-100.96%-465.00K
-100.52%-70.00K
-45.67%14.83M
139.56%32.58M
243.66%48.44M
-62.59%13.53M
1326.71%27.29M
-34.09%-82.35M
-7927.62%-33.72M
4415.39%36.16M
238.93%1.91M
-14384.43%-61.41M
77.81%-420.00K
-57.82%-838.00K
37.72%-1.38M
50.29%-424.00K
51.68%-1.89M
82.05%-531.00K
-59.64%-2.21M
36.49%-853.00K
Net financing
-14.66%99.00K
100.00%0.00
-99.84%73.00K
-100.00%0.00
-99.93%116.00K
-303.49%-525.00K
240373.68%45.69M
588.10%1.23M
19.10%161.59M
--258.00K
-82.41%19.00K
-100.87%-252.00K
437564.52%135.68M
-100.00%0.00
-10.00%108.00K
-67.85%29.13M
104.52%31.00K
-99.91%88.00K
200.00%120.00K
9060700.00%90.61M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its total revenue reached 10.32M, with a year-on-year change of 2.82M.

What are the current assets of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its current assets were 157.21M, with a year-on-year change of -46.29.

What are the total assets of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its total assets of TScan Therapeutics Inc were 228.79M, with a year-on-year change of -38.35.

What are the total liabilities of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its total liabilities of TScan Therapeutics Inc were 105.67M, with a year-on-year change of -18.81.

What is the total equity of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its total equity of TScan Therapeutics Inc was 123.12M, with a year-on-year change of -48.91.

What is the net operating income of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its net operating income of TScan Therapeutics Inc was -133.81M, with a year-on-year change of 0.75.

What is the net investment of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its net investment of TScan Therapeutics Inc was 109.37M, with a year-on-year change of 307.88.

What is the net financing of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its net financing of TScan Therapeutics Inc was -336.00K, with a year-on-year change of -100.16.

What is the Earnings Per Share (EPS) of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.00, with a year-on-year change of 12.17.

What is the net income of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its net income was -129.77M, with a year-on-year change of -1.78.

What is the net margin of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its net profit margin was -1256.81, with a year-on-year change of 72.24.

What is the debt-to-asset ratio of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 14.22, with a year-on-year change of 64.55.

What is the Return on Equity (ROE) of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -71.28, with a year-on-year change of -9.53.

What is the Return on Assets (ROA) of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -43.26, with a year-on-year change of -9.13.

What is the operating profit of TScan Therapeutics Inc?

According to TScan Therapeutics Inc's FY2025 earnings report, its operating profit was -133.81M, with a year-on-year change of 0.75.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy